Bax regulates c-Myc-induced mammary tumour apoptosis but not proliferation in MMTV-c-myc transgenic mice
暂无分享,去创建一个
S. Korsmeyer | R. Dickson | P. Furth | M. Jamerson | M. Johnson | M Hunter Jamerson | MD Johnson | SJ Korsmeyer | PA Furth | RB Dickson
[1] K. Gilchrist,et al. Strain background alters mammary gland lesion phenotype in transforming growth factor-alpha transgenic mice. , 2002, The American journal of pathology.
[2] S. Korsmeyer,et al. c-Myc Functionally Cooperates with Bax To Induce Apoptosis , 2002, Molecular and Cellular Biology.
[3] S. Korsmeyer,et al. Loss of Bax alters tumor spectrum and tumor numbers in ARF-deficient mice. , 2002, Cancer research.
[4] S. Korsmeyer,et al. Bax Loss Impairs Myc-Induced Apoptosis and Circumvents the Selection of p53 Mutations during Myc-Mediated Lymphomagenesis , 2001, Molecular and Cellular Biology.
[5] S. Markowitz,et al. MMTV promoter hypomethylation is linked to spontaneous and MNU associated c-neu expression and mammary carcinogenesis in MMTV c-neu transgenic mice , 2001, Oncogene.
[6] M. Roussel,et al. Apoptosis Triggered by Myc-Induced Suppression of Bcl-XL or Bcl-2 Is Bypassed during Lymphomagenesis , 2001, Molecular and Cellular Biology.
[7] D. Andrews,et al. Myc Potentiates Apoptosis by Stimulating Bax Activity at the Mitochondria , 2001, Molecular and Cellular Biology.
[8] S. Korsmeyer,et al. Proapoptotic BAX and BAK: A Requisite Gateway to Mitochondrial Dysfunction and Death , 2001, Science.
[9] R. Cardiff,et al. c-MYC induces mammary tumorigenesis by means of a preferred pathway involving spontaneous Kras2 mutations , 2001, Nature Medicine.
[10] B. Trock,et al. C-myc amplification in breast cancer: a meta-analysis of its occurrence and prognostic relevance , 2000, British Journal of Cancer.
[11] John Calvin Reed,et al. Bax is a transcriptional target and mediator of c-myc-induced apoptosis. , 2000, Cancer research.
[12] K. Hunter,et al. An epistatic interaction controls the latency of a transgene-induced mammary tumor , 2000, Mammalian Genome.
[13] V. Steele,et al. Bcl-2 and Bax are differentially expressed in hyperplastic, premalignant, and malignant lesions of mammary carcinogenesis. , 2000, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[14] John Calvin Reed,et al. The Putative Pore-Forming Domain of Bax Regulates Mitochondrial Localization and Interaction with Bcl-XL , 2000, Molecular and Cellular Biology.
[15] R. Dickson,et al. Dual regulation of proliferation and apoptosis: c-myc in bitransgenic murine mammary tumor models , 2000, Oncogene.
[16] R. Cardiff,et al. The mammary pathology of genetically engineered mice: the consensus report and recommendations from the Annapolis meeting‡ , 2000, Oncogene.
[17] J. Martinou,et al. Bax oligomerization is required for channel-forming activity in liposomes and to trigger cytochrome c release from mitochondria. , 2000, The Biochemical journal.
[18] K. Murphy,et al. Bax membrane insertion during Fas(CD95)-induced apoptosis precedes cytochrome c release and is inhibited by Bcl-2 , 1999, Oncogene.
[19] D. Felsher,et al. Reversible tumorigenesis by MYC in hematopoietic lineages. , 1999, Molecular cell.
[20] E. Schröck,et al. A recurring pattern of chromosomal aberrations in mammary gland tumors of MMTV‐cmyc transgenic mice , 1999, Genes, chromosomes & cancer.
[21] S. Korsmeyer,et al. Gain of Bcl-2 is more potent than bax loss in regulating mammary epithelial cell survival in vivo. , 1999, Cancer research.
[22] G. Evan,et al. c-Myc-induced sensitization to apoptosis is mediated through cytochrome c release. , 1999, Genes & development.
[23] S. Korsmeyer,et al. Haploid loss of bax leads to accelerated mammary tumor development in C3(1)/SV40‐TAg transgenic mice: reduction in protective apoptotic response at the preneoplastic stage , 1999, The EMBO journal.
[24] G. Prendergast,et al. Mechanisms of apoptosis by c-Myc , 1999, Oncogene.
[25] J. Reed,et al. Bcl-2 Gene Family and Related Proteins in Mammary Gland Involution and Breast Cancer , 1999, Journal of Mammary Gland Biology and Neoplasia.
[26] D. Felsher,et al. Transient excess of MYC activity can elicit genomic instability and tumorigenesis. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[27] Jean-Claude Martinou,et al. Bid-induced Conformational Change of Bax Is Responsible for Mitochondrial Cytochrome c Release during Apoptosis , 1999, The Journal of cell biology.
[28] Chi V. Dang,et al. c-Myc Target Genes Involved in Cell Growth, Apoptosis, and Metabolism , 1999, Molecular and Cellular Biology.
[29] N. Drinkwater,et al. Multiple genetic loci modify risk for retinoblastoma in transgenic mice. , 1998, Investigative ophthalmology & visual science.
[30] K. Franssila,et al. A multivariate analysis of tumour biological factors predicting response to cytotoxic treatment in advanced breast cancer. , 1998, British Journal of Cancer.
[31] K. Buetow,et al. Identification of inbred mouse strains harboring genetic modifiers of mammary tumor age of onset and metastatic progression , 1998, International journal of cancer.
[32] J L Cleveland,et al. Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization. , 1998, Genes & development.
[33] S. Ritland,et al. Genetic modulation of neu proto-oncogene-induced mammary tumorigenesis. , 1998, Cancer research.
[34] T. Ried,et al. Myc/p53 interactions in transgenic mouse mammary development, tumorigenesis and chromosomal instability , 1998, Oncogene.
[35] J C Reed,et al. Bax directly induces release of cytochrome c from isolated mitochondria. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[36] R. Jäger,et al. Overexpression of Bcl-2 inhibits alveolar cell apoptosis during involution and accelerates c-myc-induced tumorigenesis of the mammary gland in transgenic mice , 1997, Oncogene.
[37] F Gambale,et al. Inhibition of Bax channel-forming activity by Bcl-2. , 1997, Science.
[38] E. Kouri,et al. Prognostic significance of apoptosis related proteins Bcl-2 and Bax in node-negative breast cancer patients. , 1997, Anticancer research.
[39] S. Nass,et al. Defining a role for c-Myc in breast tumorigenesis , 1997, Breast Cancer Research and Treatment.
[40] G. Brem,et al. Epigenetic modification of transgenes under the control of the mouse mammary tumor virus LTR: tissue-dependent influence on transcription of the transgenes. , 1996, Biological chemistry.
[41] L. Amundadottir,et al. Cooperation of TGF alpha and c-Myc in mouse mammary tumorigenesis: coordinated stimulation of growth and suppression of apoptosis. , 1996, Oncogene.
[42] T Takahashi,et al. Overexpression of bax sensitizes human breast cancer MCF‐7 cells to radiation‐induced apoptosis , 1996, International journal of cancer.
[43] B. Dörken,et al. Overexpression of the death-promoting gene bax-alpha which is downregulated in breast cancer restores sensitivity to different apoptotic stimuli and reduces tumor growth in SCID mice. , 1996, The Journal of clinical investigation.
[44] S. Korsmeyer,et al. Bax-Deficient Mice with Lymphoid Hyperplasia and Male Germ Cell Death , 1995, Science.
[45] A. Pellicer,et al. Promoter demethylation in MMTV/N‐rasN transgenic mice required for transgene expression and tumorigenesis , 1995, Molecular carcinogenesis.
[46] K. Franssila,et al. Reduced expression of proapoptotic gene BAX is associated with poor response rates to combination chemotherapy and shorter survival in women with metastatic breast adenocarcinoma. , 1995, Cancer research.
[47] R. Palmiter,et al. Inhibition of mammary gland involution is associated with transforming growth factor alpha but not c-myc-induced tumorigenesis in transgenic mice. , 1995, Cancer research.
[48] J. Cleveland,et al. c-Myc and apoptosis. , 1995, Biochimica et biophysica acta.
[49] L. Donehower,et al. The MMTV/c-myc transgene and p53 null alleles collaborate to induce T-cell lymphomas, but not mammary carcinomas in transgenic mice. , 1995, Oncogene.
[50] L. Amundadottir,et al. Synergistic interaction of transforming growth factor alpha and c-myc in mouse mammary and salivary gland tumorigenesis. , 1995, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[51] B. Dörken,et al. Expression of the bcl‐2 gene family in normal and malignant breast tissue: Low bax‐α expression in tumor cells correlates with resistance towards apoptosis , 1995, International journal of cancer.
[52] John Calvin Reed,et al. Immunohistochemical determination of in vivo distribution of Bax, a dominant inhibitor of Bcl-2. , 1994, The American journal of pathology.
[53] G. Evan,et al. c‐Myc‐induced apoptosis in fibroblasts is inhibited by specific cytokines. , 1994, The EMBO journal.
[54] S. Korsmeyer,et al. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell death , 1993, Cell.
[55] G. Evan,et al. The role of c-myc in cell growth. , 1993, Current opinion in genetics & development.
[56] R. Strange,et al. Apoptotic cell death and tissue remodelling during mouse mammary gland involution. , 1992, Development.
[57] Gerard I. Evan,et al. Induction of apoptosis in fibroblasts by c-myc protein , 1992, Cell.
[58] G. Merlo,et al. Stromal influences on transformation of human mammary epithelial cells overexpressing c‐myc and SV40T , 1990, Journal of cellular physiology.
[59] M. Osborne,et al. Neoplastic transformation of mouse mammary epithelial cells by deregulated myc expression. , 1990, Cell regulation.
[60] R. Palmiter,et al. Overexpression of TGFα in transgenic mice: Induction of epithelial hyperplasia, pancreatic metaplasia, and carcinoma of the breast , 1990, Cell.
[61] G. Merlino,et al. TGFα overexpression in transgenic mice induces liver neoplasia and abnormal development of the mammary gland and pancreas , 1990, Cell.
[62] B. Hogan,et al. Development of mammary hyperplasia and neoplasia in MMTV-TGFα transgenic mice , 1990, Cell.
[63] P. Leder,et al. Consequences of widespread deregulation of the c-myc gene in transgenic mice: Multiple neoplasms and normal development , 1986, Cell.
[64] P. Leder,et al. Spontaneous mammary adenocarcinomas in transgenic mice that carry and express MTV/myc fusion genes , 1984, Cell.
[65] B. Vennstrom,et al. Isolation and characterization of c-myc, a cellular homolog of the oncogene (v-myc) of avian myelocytomatosis virus strain 29 , 1982, Journal of virology.
[66] R. Brown,et al. BCL-2 Family Proteins , 2019, Methods in Molecular Biology.
[67] S. Thorgeirsson,et al. Disruption of the pRb / E 2 F Pathway and Inhibition of Apoptosis Are Major Oncogemc Events in Liver Constitutively Expressing c-myc and Transforming Growth Factor a , 2006 .
[68] T. Dimpfl,et al. Immunohistochemical analysis of Bcl-2 and Bax expression in relation to cell turnover and epithelial differentiation markers in the non-lactating human mammary gland epithelium , 1999, Cell and Tissue Research.
[69] N. J. McNally,et al. United Kingdom Co-ordinating Committee on Cancer Research (UKCCCR) Guidelines for the Welfare of Animals in Experimental Neoplasia (Second Edition). , 1998, British Journal of Cancer.
[70] S. Thorgeirsson,et al. Disruption of the pRb/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-myc and transforming growth factor alpha. , 1998, Cancer research.
[71] D. Brewster,et al. Trends in cancer incidence and mortality in Scotland: description and possible explanations. , 1998, British Journal of Cancer.
[72] L. Hennighausen,et al. Apoptosis and remodeling of mammary gland tissue during involution proceeds through p53-independent pathways. , 1996, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[73] John Calvin Reed,et al. Bcl-2 family proteins and the regulation of programmed cell death in leukemia and lymphoma. , 1996, Cancer treatment and research.
[74] S. Snedeker,et al. Expression and functional properties of transforming growth factor alpha and epidermal growth factor during mouse mammary gland ductal morphogenesis. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[75] B. Hogan,et al. Development of mammary hyperplasia and neoplasia in MMTV-TGF alpha transgenic mice. , 1990, Cell.
[76] S. Bates,et al. Expression of the transforming growth factor-alpha/epidermal growth factor receptor pathway in normal human breast epithelial cells. , 1990, Endocrinology.
[77] S. Bates,et al. Expression of the transforming growth factor-alpha/epidermal growth factor receptor pathway in normal human breast epithelial cells. , 1990, Endocrinology.